Financial Instruments

9 Months Ended

Sep. 30, 2017

Investments, Debt and Equity Securities [Abstract]

Restricted Cash and Cash Equivalents

The Company had restricted cash and cash equivalents of $31,682 at September 30, 2017, which was primarily related to balances that are restricted for payment of distributions to certain of the Company's current and former employees. The Company had restricted cash and cash equivalents of $186,216 at December 31, 2016, which was primarily related to balances deposited with and held as security by the lender under the Company's term loan facility and for distributions to certain of the Company's current and former employees. The current portion of restricted cash and cash equivalents was $8,626 and $160,527 at September 30, 2017 and December 31, 2016, respectively. The noncurrent portion of restricted cash and cash equivalents was $23,056 and $25,689 at September 30, 2017 and December 31, 2016, respectively, and is reflected in deferred charges and other assets, net in the consolidated balance sheets.

Available-for-Sale Marketable Securities

The Company had no available-for-sale securities at September 30, 2017 or at December 31, 2016.

There were no sales or maturities of available-for-sale securities during the three and nine months ended September 30, 2017. The proceeds from sales and maturities of available-for-sale securities included in the consolidated statement of cash flows and the gross realized gains and losses included in the consolidated statement of operations for the three and nine months ended September 30, 2016 are reflected in the table below. The cost of securities sold was determined using the specific identification method.



	Three Months Ended September 30,			Nine Months Ended September 30,
	2016			2016
Proceeds from sales and maturities of securities	$	360,506		$	662,938
Gross realized gains	52,414			53,755
Gross realized losses	(13		)	(35		)